Effect of COVID-19 on colorectal cancer care in England
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
During the rise of the COVID-19 pandemic in spring, 2020, unprecedented pressure on hospital beds and intensive care units (ICUs), redeployment of staff, caution regarding nosocomial transmission, reduced primary care access, and population lockdown combined in a perfect storm, dramatically disrupting UK cancer care pathways.1 It was predicted that colorectal cancer care might fare particularly badly, in particular due to suspension of non-emergency diagnostic endoscopy following safety concerns from the British Society of Gastroenterology, discontinuation of the National Bowel Cancer Screening programme, recommendation by the Royal College of Surgeons against laparoscopic procedures, and shortage of ICU capacity to support open bowel resections.
The Lancet Gastroenterology & Hepatology , commentaire, 2020